2022-01-012022-12-312022-12-31false08112186SCAMALYTICS LTD2023-10-2462090iso4217:GBPxbrli:pure081121862022-01-01081121862022-12-31081121862022-01-012022-12-31081121862020-12-21081121862021-12-31081121862020-12-212021-12-3108112186bus:SmallEntities2022-01-012022-12-3108112186bus:AuditExempt-NoAccountantsReport2022-01-012022-12-3108112186bus:AbridgedAccounts2022-01-012022-12-3108112186bus:PrivateLimitedCompanyLtd2022-01-012022-12-3108112186core:WithinOneYear2022-12-3108112186core:AfterOneYear2022-12-3108112186core:WithinOneYear2021-12-3108112186core:AfterOneYear2021-12-3108112186core:ShareCapital2022-12-3108112186core:SharePremium2022-12-3108112186core:RevaluationReserve2022-12-3108112186core:OtherReservesSubtotal2022-12-3108112186core:RetainedEarningsAccumulatedLosses2022-12-3108112186core:ShareCapital2021-12-3108112186core:SharePremium2021-12-3108112186core:RevaluationReserve2021-12-3108112186core:OtherReservesSubtotal2021-12-3108112186core:RetainedEarningsAccumulatedLosses2021-12-3108112186core:LandBuildings2022-12-3108112186core:PlantMachinery2022-12-3108112186core:Vehicles2022-12-3108112186core:FurnitureFittings2022-12-3108112186core:OfficeEquipment2022-12-3108112186core:NetGoodwill2022-12-3108112186core:IntangibleAssetsOtherThanGoodwill2022-12-3108112186core:ListedExchangeTraded2022-12-3108112186core:UnlistedNon-exchangeTraded2022-12-3108112186core:LandBuildings2021-12-3108112186core:PlantMachinery2021-12-3108112186core:Vehicles2021-12-3108112186core:FurnitureFittings2021-12-3108112186core:OfficeEquipment2021-12-3108112186core:NetGoodwill2021-12-3108112186core:IntangibleAssetsOtherThanGoodwill2021-12-3108112186core:ListedExchangeTraded2021-12-3108112186core:UnlistedNon-exchangeTraded2021-12-3108112186core:LandBuildings2022-01-012022-12-3108112186core:PlantMachinery2022-01-012022-12-3108112186core:Vehicles2022-01-012022-12-3108112186core:FurnitureFittings2022-01-012022-12-3108112186core:OfficeEquipment2022-01-012022-12-3108112186core:NetGoodwill2022-01-012022-12-3108112186core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3108112186core:ListedExchangeTraded2022-01-012022-12-3108112186core:UnlistedNon-exchangeTraded2022-01-012022-12-3108112186core:MoreThanFiveYears2022-01-012022-12-3108112186core:Non-currentFinancialInstruments2022-12-3108112186core:Non-currentFinancialInstruments2021-12-3108112186dpl:CostSales2022-01-012022-12-3108112186dpl:DistributionCosts2022-01-012022-12-3108112186dpl:AdministrativeExpenses2022-01-012022-12-3108112186core:LandBuildings2022-01-012022-12-3108112186core:PlantMachinery2022-01-012022-12-3108112186core:Vehicles2022-01-012022-12-3108112186core:FurnitureFittings2022-01-012022-12-3108112186core:OfficeEquipment2022-01-012022-12-3108112186core:NetGoodwill2022-01-012022-12-3108112186core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3108112186dpl:GroupUndertakings2022-01-012022-12-3108112186dpl:ParticipatingInterests2022-01-012022-12-3108112186dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3108112186core:ListedExchangeTraded2022-01-012022-12-3108112186dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3108112186core:UnlistedNon-exchangeTraded2022-01-012022-12-3108112186dpl:CostSales2020-12-212021-12-3108112186dpl:DistributionCosts2020-12-212021-12-3108112186dpl:AdministrativeExpenses2020-12-212021-12-3108112186core:LandBuildings2020-12-212021-12-3108112186core:PlantMachinery2020-12-212021-12-3108112186core:Vehicles2020-12-212021-12-3108112186core:FurnitureFittings2020-12-212021-12-3108112186core:OfficeEquipment2020-12-212021-12-3108112186core:NetGoodwill2020-12-212021-12-3108112186core:IntangibleAssetsOtherThanGoodwill2020-12-212021-12-3108112186dpl:GroupUndertakings2020-12-212021-12-3108112186dpl:ParticipatingInterests2020-12-212021-12-3108112186dpl:GroupUndertakingscore:ListedExchangeTraded2020-12-212021-12-3108112186core:ListedExchangeTraded2020-12-212021-12-3108112186dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2020-12-212021-12-3108112186core:UnlistedNon-exchangeTraded2020-12-212021-12-3108112186core:NetGoodwill2022-12-3108112186core:IntangibleAssetsOtherThanGoodwill2022-12-3108112186core:LandBuildings2022-12-3108112186core:PlantMachinery2022-12-3108112186core:Vehicles2022-12-3108112186core:FurnitureFittings2022-12-3108112186core:OfficeEquipment2022-12-3108112186core:AfterOneYear2022-12-3108112186core:WithinOneYear2022-12-3108112186core:ListedExchangeTraded2022-12-3108112186core:UnlistedNon-exchangeTraded2022-12-3108112186core:ShareCapital2022-12-3108112186core:SharePremium2022-12-3108112186core:RevaluationReserve2022-12-3108112186core:OtherReservesSubtotal2022-12-3108112186core:RetainedEarningsAccumulatedLosses2022-12-3108112186core:NetGoodwill2021-12-3108112186core:IntangibleAssetsOtherThanGoodwill2021-12-3108112186core:LandBuildings2021-12-3108112186core:PlantMachinery2021-12-3108112186core:Vehicles2021-12-3108112186core:FurnitureFittings2021-12-3108112186core:OfficeEquipment2021-12-3108112186core:AfterOneYear2021-12-3108112186core:WithinOneYear2021-12-3108112186core:ListedExchangeTraded2021-12-3108112186core:UnlistedNon-exchangeTraded2021-12-3108112186core:ShareCapital2021-12-3108112186core:SharePremium2021-12-3108112186core:RevaluationReserve2021-12-3108112186core:OtherReservesSubtotal2021-12-3108112186core:RetainedEarningsAccumulatedLosses2021-12-3108112186core:NetGoodwill2020-12-2108112186core:IntangibleAssetsOtherThanGoodwill2020-12-2108112186core:LandBuildings2020-12-2108112186core:PlantMachinery2020-12-2108112186core:Vehicles2020-12-2108112186core:FurnitureFittings2020-12-2108112186core:OfficeEquipment2020-12-2108112186core:AfterOneYear2020-12-2108112186core:WithinOneYear2020-12-2108112186core:ListedExchangeTraded2020-12-2108112186core:UnlistedNon-exchangeTraded2020-12-2108112186core:ShareCapital2020-12-2108112186core:SharePremium2020-12-2108112186core:RevaluationReserve2020-12-2108112186core:OtherReservesSubtotal2020-12-2108112186core:RetainedEarningsAccumulatedLosses2020-12-2108112186core:AfterOneYear2022-01-012022-12-3108112186core:WithinOneYear2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:CostValuation2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3108112186core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3108112186core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3108112186core:Non-currentFinancialInstrumentscore:CostValuation2021-12-3108112186core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-12-3108112186core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-12-3108112186bus:Director12022-01-012022-12-3108112186bus:Director22022-01-012022-12-31

SCAMALYTICS LTD

Registered Number
08112186
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2022

SCAMALYTICS LTD
Company Information
for the year from 1 January 2022 to 31 December 2022

Directors

TSINONIS, Nikolaos
WINCHESTER, Daniel Paul

Registered Address

7 Bell Yard
London
WC2A 2JR

Registered Number

08112186 (England and Wales)
SCAMALYTICS LTD
Balance Sheet as at
31 December 2022

Notes

2022

2021

£

£

£

£

Current assets
Debtors651,54549,863
Cash at bank and on hand28,30322,264
79,84872,127
Creditors amounts falling due within one year7(29,629)(5,939)
Net current assets (liabilities)50,21966,188
Total assets less current liabilities50,21966,188
Net assets50,21966,188
Capital and reserves
Called up share capital100100
Profit and loss account50,11966,088
Shareholders' funds50,21966,188
The financial statements were approved and authorised for issue by the Board of Directors on 24 October 2023, and are signed on its behalf by:
TSINONIS, Nikolaos
Director
Registered Company No. 08112186
SCAMALYTICS LTD
Notes to the Financial Statements
for the year ended 31 December 2022

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Research and development policy
Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when It is technically feasible to complete the intangible asset so that it will be available for use or sale; there is the intention to complete the intangible asset and use or sell it; there is the ability to use or sell the intangible asset; the use or sale of the intangible asset will generate probable future economic benefits; there are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and the expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
4.Employee information

20222021
Average number of employees during the year22
5.Property, plant and equipment

Total

£
Cost or valuation
At 01 January 221,199
At 31 December 221,199
Depreciation and impairment
At 01 January 221,199
At 31 December 221,199
Net book value
At 31 December 22-
At 31 December 21-
6.Debtors

2022

2021

££
Trade debtors / trade receivables24,47822,877
Other debtors27,06726,986
Total51,54549,863
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
7.Creditors within one year

2022

2021

££
Trade creditors / trade payables29,0294,139
Bank borrowings and overdrafts600600
Accrued liabilities and deferred income-1,200
Total29,6295,939
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.